The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. METHOD: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. RESULTS: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. CONCLUSION: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is significant contributor to the global burden of disease [7, 43].”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anxiety disorders cause 10.4% of the Disability Adjusted Life Years (DALYs) lost due to neurological, mental, substance use disorders and account for 1.1% of the global burden of disease worldwide, that is a total of 26,800,000 DALYs worldwide (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As described above, postpartum psychosis is a key marker for the risk of future affective disorder”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“In 2010, mental, neurological and substance abuse disorders accounted for 10.4% of all disability-adjusted life-years globally.21”
From Climate change, climate-related disasters and mental disorder in low- and middle-income countries: a scoping review (2021) · cites this paper as [21]
In the citing paper
“Recent prevalence estimates indicate 10.7% of the world’s population live with a mental health disorder, and the number of years lived with a mental health disorder has increased by 13.5% from 2007 to 2017”
From Explaining adults’ mental health help-seeking through the lens of the theory of planned behavior: A scoping review (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 7×
“Overall, GBD 2010 findings highlighted a shift in burden from communicable to noncommunicable diseases and from YLLs to YLDs [1,11].”
InfluentialSelf-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationWorld Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
(1996) · Cited by 6,884
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Self-citationDiagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Self-citation
Cited by
Items 101–200 of 1,000
Silva, A. R., Sgnaolin, V., Nogueira, E. L., Loureiro, F., Engroff, P., & Gomes, I. (2017) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000149 · Cited by 163
Wakida, E. K., Akena, D., Okello, E. S., Kinengyere, A., Kamoga, R., Mindra, A., Obua, C., & Talib, Z. M. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0561-0 · Cited by 105
Internet interventions for adult illicit substance users: a meta‐analysis
Boumparis, N., Karyotaki, E., Schaub, M. P., Cuijpers, P., & Riper, H. (2017) · Addiction · doi:10.1111/add.13819 · Cited by 104
Mugisha, J., Abdulmalik, J., Hanlon, C., Petersen, I., Lund, C., Upadhaya, N., Ahuja, S., Shidhaye, R., Mntambo, N., Alem, A., et al. (2017) · International Journal of Mental Health Systems · doi:10.1186/s13033-016-0114-2 · Cited by 103
Substance-related exogenous psychosis: a postmodern syndrome
Martinotti, G., Risio, L. D., Vannini, C., Schifano, F., Pettorruso, M., & Giannantonio, M. D. (2020) · CNS Spectrums · doi:10.1017/s1092852920001479 · Cited by 111
Lui, J. C., Sagar-Ouriaghli, I., & Brown, J. S. L. (2024) · Journal of American College Health · doi:10.1080/07448481.2022.2119859 · Cited by 102
De Carvalho, M., Dias, T., Duchesne, M., Nardi, A., & Appolinario, J. (2017) · Behavioral Sciences · doi:10.3390/bs7030043 · Cited by 96
Jaeschke, K. N., Hanna, F., Ali, S., Chowdhary, N., Dua, T., & Charlson, F. (2021) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2021.19 · Cited by 124
“Mental disorders contribute a substantial burden globally, in terms of both morbidity and mortality, and significant social and economic impacts (Whiteford et al ., 2015).”
Hölter, S. M., Garrett, L., Einicke, J., Sperling, B., Dirscherl, P., Zimprich, A., Fuchs, H., Gailus‐Durner, V., de Angelis, M. H., & Wurst, W. (2015) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo150068 · Cited by 108
“The Global Burden of Disease Study 2010 (Whiteford et al., 2015). estimated that a substantial proportion of the world’s disease burden came from mental disorders (e.g., autism, Asperger’s syndrome, attention-deficit hyperactivity disorder, and idiopathic intellectual disability), neurological…”
BackgroundTransdiagnostic treatment of depression and anxiety: a meta-analysis
Cuijpers, P., Miguel, C., Ciharova, M., Ebert, D., Harrer, M., & Karyotaki, E. (2023) · Psychological Medicine · doi:10.1017/s0033291722003841 · Cited by 96
Wood, K., Giannopoulos, V., Louie, E., Baillie, A., Guajardo, M. G. U., Lee, K. S., Haber, P., & Morley, K. C. (2020) · Implementation Research and Practice · doi:10.1177/2633489520959072 · Cited by 112
Cano-Vindel, A., Muñoz-Navarro, R., Medrano, L. A., Ruiz-Rodríguez, P., González-Blanch, C., Gómez-Castillo, M. D., Capafons, A., Chacón, F., & Santolaya, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.01.030 · Cited by 87
User Acceptance of Computerized Cognitive Behavioral Therapy for Depression: Systematic Review
Rost, T., Stein, J., Löbner, M., Kersting, A., Luck-Sikorski, C., & Riedel-Heller, S. G. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7662 · Cited by 91
Yin, M., Li, Z., & Zhou, C. (2019) · International Journal of Mental Health Nursing · doi:10.1111/inm.12668 · Cited by 108
Liu, Q., Cai, H., Yang, L. H., Xiang, Y.-B., Yang, G., Li, H., Gao, Y.-T., Zheng, W., Susser, E., & Shu, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-22175-2 · Cited by 95
Substance use and shame: A systematic and meta-analytic review
Luoma, J. B., Chwyl, C., & Kaplan, J. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.03.002 · Cited by 88
Firth, J. A., Smith, L., Sarris, J. J., Vancampfort, D., Schuch, F. B., Carvalho, A. F., Solmi, M., Yung, A. R., Stubbs, B., & Firth, J. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000753 · Cited by 90
Mills, C. (2018) · Development and Change · doi:10.1111/dech.12397 · Cited by 87
Who sells what? Country specific differences in substance availability on the Agora cryptomarket
Buskirk, J. V., Naicker, S., Roxburgh, A., Bruno, R., & Burns, L. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.07.004 · Cited by 87
“However, there does appear to be some corroboration between the listings on these cryptomarkets and published data on dark net purchasing patterns (Soska & Christin, 2015; Winstock, 2015), especially when considering substances such as cannabis, MDMA and NPS.”
Soyka, M., Kranzler, H. R., Hesselbrock, V., Kasper, S., Mutschler, J., Möller, H.-J., & The WFSBP Task Force on Treatment Guidelines for Substance Use Disorders (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1246752 · Cited by 85
“…heavy-drinking episodes may have a beneficial effect on the risk of ischaemic heart disease (Roerecke & Rehm 2014), the effect is far outweighed by the substantial psychiatric, somatic, social and economic burden caused by AUDs (Connor et al. 2015; Schoepf & Heun 2015; Whiteford et al. 2015).”
BackgroundNguyen, B., Ding, D., & Mihrshahi, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014201 · Cited by 95
Evans‐Polce, R. J., Veliz, P. T., Boyd, C. J., Hughes, T. L., & McCabe, S. E. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01694-x · Cited by 88
Nashwan, A. J., Gharib, S., Alhadidi, M., El-Ashry, A. M., Alamgir, A., Al-Hassan, M., Khedr, M. A., Dawood, S., & Abufarsakh, B. (2023) · Issues in Mental Health Nursing · doi:10.1080/01612840.2023.2263579 · Cited by 77
“Between the years 2011 till 2014, a 16% decline was seen in all sectors of mental health workers (Oladeji & Gureje, 2016), a contrast to the steep increase in disease burden caused by mental disorders (Whiteford et al., 2015).”
BackgroundCusack, E., Killoury, F., & Nugent, L. (2016) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12347 · Cited by 85
Considine, R., Tynan, R. J., James, C. L., Wiggers, J., Lewin, T. J., Inder, K., Perkins, D. A., Handley, T. E., & Kelly, B. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168445 · Cited by 94
Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa
Himmerich, H., Hotopf, M. H., Shetty, H., Schmidt, U. H., Treasure, J. L., Hayes, R. D., Stewart, R. J., & Chang, C. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0937-8 · Cited by 91
“If we look at SUD across the age range, SUD are most prevalent and most important between 10 to 40 years of age [47, 48].”
BackgroundProvision of mental healthcare for children and adolescents: a worldwide view
Rocha, T. B.-M., Graeff-Martins, A. S., Kieling, C., & Rohde, L. A. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000169 · Cited by 84
Pavlova, A., & Berkers, P. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113250 · Cited by 93
Mental Health Literacy in Healthcare Students: An Expansion of the Mental Health Literacy Scale
Chao, H.-J., Lien, Y., Kao, Y., Tasi, I.-C., Lin, H.-S., & Lin, H.-S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030948 · Cited by 87
“The Recognition of Mental Illness subscale includes items about the recognition of the most severe and common mental illnesses (schizophrenia, anxiety disorders, depression, and substance-related and addictive disorders), which can result in disability and a substantial decrease in quality of life in those with mental…”
BackgroundGallo, E. A. G., De Mola, C. L., Wehrmeister, F., Gonçalves, H., Kieling, C., & Murray, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.065 · Cited by 72
“5%) of Disability-Adjusted Life Years caused by mental, neurological, and substance use disorders in 2010 (Whiteford et al., 2015).”
BackgroundPsychiatric disorders in women with polycystic ovary syndrome
Rodriguez-Paris, D., Remlinger-Molenda, A., Kurzawa, R., Głowińska, A., Spaczyński, R., Rybakowski, F., Pawelczyk, L. A., & Banaszewska, B. (2019) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/93105 · Cited by 93
The impact of low education and poor health on unemployment varies by work life stage
van Zon, S. K. R., Reijneveld, S. A., de Leon, C. F. M., & Bültmann, U. (2017) · International Journal of Public Health · doi:10.1007/s00038-017-0972-7 · Cited by 89
Majcher, M. J., Babar, A., Lofts, A., Leung, A., Li, X., Abu-Hijleh, F. A., Smeets, N. M. B., Mishra, R. K., & Hoare, T. R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.050 · Cited by 85
Dysbiotic drift: mental health, environmental grey space, and microbiota
Logan, A. C. (2015) · Journal of Physiological Anthropology · doi:10.1186/s40101-015-0061-7 · Cited by 79
Vindel, A. C., Muñoz‐Navarro, R., Moriana, J. A., Ruiz‐Rodríguez, P., Medrano, L. A., & González‐Blanch, C. (2021) · Psychological Medicine · doi:10.1017/s0033291720005498 · Cited by 89
Bennett, D., Brayne, C., Feigin, V. L., Barker-Collo, S. L., Brainin, M., Davis, D. H. J., Gallo, V., Jetté, N., Karch, A., Kurtzke, J. F., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001866 · Cited by 85
Self-citationPrenatal and adult androgen activities in alcohol dependence
Lenz, B., Mühle, C., Braun, B., Weinland, C., Bouna-Pyrrou, P., Behrens, J., Kubis, S., Mikolaiczik, K., Muschler, M.-R., Saigali, S., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12725 · Cited by 84
Müller, C. P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.028 · Cited by 80
Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review
Smith, K. S., Greene, M. W., Babu, J. R., & Frugé, A. D. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1701220 · Cited by 88
“Depression and anxiety both rank in the top five mental and physical conditions that affect Americans [1].”
BackgroundVancampfort, D., Hallgren, M. Å., Schuch, F. B., Stubbs, B., Smith, L., Rosenbaum, S., Firth, J., Damme, T. V., & Koyanagi, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.066 · Cited by 78
Prom, M. C., Denduluri, A., Philpotts, L. L., Rondón, M. B., Borba, C. P. C., Gelaye, B., & Byatt, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.859341 · Cited by 89
Alfalahi, H., Khandoker, A. H., Chowdhury, N., Iakovakis, D., Dias, S. B., Chaudhuri, К. R., & Hadjileontiadis, L. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-11865-7 · Cited by 88
Prevalence of Psychiatric Disorders in Iran: A Systematic Review and Meta-analysis
Mirghaed, M. T., Gorji, H. A., & Panahi, S. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_510_18 · Cited by 74
“[3] According to the conducted studies, psychiatric disorders are one of the most important and significant components of the overall burden of diseases.”
BackgroundZhou, S., Gao, L., Liu, F., Tian, W., Jin, Y., & Zheng, Z. (2021) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1894 · Cited by 78
Air and Noise Pollution Exposure in Early Life and Mental Health From Adolescence to Young Adulthood
Newbury, J. B., Heron, J. E., Kirkbride, J. B., Fisher, H. L., Bakolis, I., Boyd, A., Thomas, R., & Zammit, S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.12169 · Cited by 85
Zuelli, F. M. D. G. C., Brognara, F., Quirino, G. F. S., Hiroki, C. H., Fais, R. S., Del‐Ben, C. M., Ulloa, L., Salgado, H. C., Kanashiro, A., & Loureiro, C. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00618 · Cited by 76
Global Burden of Pediatric Neurological Disorders
Newton, C. R. J. C. (2018) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2018.03.002 · Cited by 73
“Mental Health” as Defined by Twitter: Frames, Emotions, Stigma
Pavlova, A., & Berkers, P. (2020) · Health Communication · doi:10.1080/10410236.2020.1862396 · Cited by 84
“Mental illness is the leading cause of disability worldwide (Whiteford et al., 2015).”
BackgroundPrevalence of Mental Disorders in Uganda: a Systematic Review and Meta-Analysis
Opio, J. N., Munn, Z., & Aromataris, E. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09941-8 · Cited by 79
Novel trends and opportunities for microencapsulation of flaxseed oil in foods: A review
Kouamé, K. J. E., Bora, A. F. M., Li, X., Sun, Y., & Liu, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104812 · Cited by 78
Ashdown-Franks, G., Sabiston, C. M., & Stubbs, B. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000526 · Cited by 63
Thomson, E. M., Filiatreault, A., & Guénette, J. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108717 · Cited by 76
Khalid, A., Qadir, F., Chan, S. W. Y., & Schwannauer, M. (2018) · Journal of Mental Health · doi:10.1080/09638237.2018.1521919 · Cited by 85
“…with the previous research examining prevalence rates of depression and anxiety across developmental stages of adolescence (Hoek, Van Lier, & Koot, 2012; Piccinelli & Wilkinson, 2000) but contradicts Whiteford et al. (2015) who reported a positive association between age and poor mental health.”
BackgroundWhite Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia
Xiao, Y., Sun, H., Shi, S., Jiang, D., Bo, T., Zhao, Y., Zhang, W., Gong, Q., Sweeney, J. A., & Lui, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17121402 · Cited by 69
Peterson, C. T., Bauer, S. M., Chopra, D., Mills, P. J., & Maturi, R. K. (2017) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587217730934 · Cited by 79
Butterworth, P., Watson, N., & Wooden, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595696 · Cited by 71
The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review
Martin-Key, N. A., Spadaro, B., Funnell, E. L., Barker, E., Schei, T. S., Tomasik, J., & Bahn, S. (2021) · JMIR Mental Health · doi:10.2196/32824 · Cited by 71
Nanozyme enabled protective therapy for neurological diseases
Cheng, F., Kotha, S., Fu, M., Yang, Q., Wang, H., He, W., & Mao, X. (2024) · Nano Today · doi:10.1016/j.nantod.2023.102142 · Cited by 67
Effects of behavioural activation on substance use and depression: a systematic review
Martínez-Vispo, C., Martínez, Ú., López-Durán, A., Fernández del Río, E., & Becoña, E. (2018) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-018-0173-2 · Cited by 63
“Keywords: Behaviour therapy, Behavioural activation, Substance use disorder, Depression, Systematic review Introduction Substance use disorders (SUDs) and mental health disorders are significant contributors to the global burden of disease, and their impact is increasing over the years both in high-income and low-to-m…”
Cannabis Epidemiology: A Selective Review
Anthony, J. C., Lopez‐Quintero, C., & Alshaarawy, O. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160813214023 · Cited by 74
The China Mental Health Survey (CMHS): I. background, aims and measures
Huang, Y., Liu, Z., Hong, W., Guan, X., Chen, H., Ma, C., Li, Q., Yan, J., Yu, Y., Kou, C., et al. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1270-z · Cited by 67
“The prevalence and disease burden of mental disorders have remained incredibly high globally [1].”
BackgroundTherapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases
Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0474-4 · Cited by 72
Fikretoglu, D., Liu, A., Nazarov, A., & Blackler, K. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2287-0 · Cited by 67
“health problem [1, 2] with significant economic costs [3].”
BackgroundUpadhaya, N., Regmi, U., Gurung, D., Luitel, N. P., Petersen, I., Jordans, M. J. D., & Komproe, I. H. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2476-x · Cited by 74
Diet and Mental Health During Emerging Adulthood: A Systematic Review
Collins, S., Dash, S. R., Allender, S. E., Jacka, F. N., & Hoare, E. (2020) · Emerging Adulthood · doi:10.1177/2167696820943028 · Cited by 75
Beyond CGRP: The calcitonin peptide family as targets for migraine and pain
Rees, T. A., Hendrikse, E. R., Hay, D. L., & Walker, C. S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15605 · Cited by 69
“The most prevalent of these is migraine, which affects approximately one billion people and is the sixth highest cause of disability, defined using disability-adjusted life years as suggested by the World Health Organisation (Whiteford et al., 2015).”
BackgroundYap, M. B., Lawrence, K. A., Rapee, R. M., Cardamone-Breen, M. C., Green, J., & Jorm, A. F. (2017) · JMIR Mental Health · doi:10.2196/mental.8492 · Cited by 63
“Depression and anxiety disorders are the largest contributors to disease burden in young people globally [1].”
Tilahun, D., Hanlon, C., Araya, M., Davey, B., Hoekstra, R. A., & Fekadu, A. (2017) · International Journal of Mental Health Systems · doi:10.1186/s13033-017-0121-y · Cited by 69
Depressive symptoms, handgrip strength, and weight status in US older adults
Smith, L., Stockwell, S., Stubbs, B., Hu, L., Veronese, N., Vancampfort, D., Hamer, M., Gardner, B., & Yang, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.016 · Cited by 63
Causes of drug discontinuation in patients with major depressive disorder in China
Zhu, Y., Wu, Z., Sie, O., Cai, Y., Huang, J., Liu, H., Yao, Y., Niu, Z., Wu, X., Shi, Y., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109755 · Cited by 64
Rane, A., Church, S., Bhatia, U., Orford, J., Velleman, R. D. B., & Nadkarni, A. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.05.015 · Cited by 62
Molecular genetics of substance use disorders: An umbrella review
López‐León, S., González‐Giraldo, Y., Wegman-Ostrosky, T., & Forero, D. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.019 · Cited by 68
Smith, L., Shin, J. I., McDermott, D. T., Jacob, L., Barnett, Y., Sánchez, G. F. L., Veronese, N., Yang, L., Soysal, P., Oh, H. Y., et al. (2021) · Depression and Anxiety · doi:10.1002/da.23147 · Cited by 63
“5% of total disability‐adjusted life years caused by mental and substance use disorders (Whiteford et al., 2015).”
BackgroundInfluentialHockey, M., Rocks, T., Ruusunen, A. A., Jacka, F. N., Huang, W., Liao, B., Aune, D., Wang, Y., Nie, J., & O'Neil, A. E. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02116-7 · Cited by 65
Self‐stigma and the intention to seek psychological help online compared to face‐to‐face
Wallin, E., Maathz, P., Parling, T., & Hursti, T. (2018) · Journal of Clinical Psychology · doi:10.1002/jclp.22583 · Cited by 60
Machine learning, artificial intelligence and the prediction of dementia
Merkin, A., Krishnamurthi, R., & Medvedev, O. N. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000768 · Cited by 63
Newmyer, L., Verdery, A. M., Wang, H., & Margolis, R. (2022) · Population and Development Review · doi:10.1111/padr.12506 · Cited by 69
Chávez-Castillo, M., Núñez, V., Nava, M., Ortega, Á., Rojas, M., Bermúdez, V., & Rojas, J. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/7943481 · Cited by 72
“Depression is one of the most frequent mental disorders in everyday clinical practice and is currently regarded as the leading cause of disability worldwide [1].”
BackgroundSecor, A., Macauley, R., Stan, L., Kagone, M., Sidibé, S., Sow, S., Aronovich, D., Litvin, K., Davis, N., Alva, S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035217 · Cited by 67
Triana, R., Keliat, B. A., & Sulistiowati, N. M. D. (2019) · Humanities & Social Sciences Reviews · doi:10.18510/hssr.2019.715 · Cited by 76
“As many as 10-20% of mental disorders occur at the age of 10-29 years and exhibiting the highest occurrence of emotional disturbance (Merikangas et al., 2011; Whiteford et al., 2015).”
BackgroundLizano, P. L., Keshavan, M. S., Tandon, N., Mathew, I. T., Mothi, S. S., Montrose, D. M., & Yao, J. K. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.12.001 · Cited by 63
“Schizophrenia (SZ) is a complex disorder with clinical features that typically present in adolescence, persist into adulthood, and have a considerable impact on morbidity, mortality, and cost (Whiteford et al., 2015; Lee et al., 2014).”
BackgroundMunetsi, E., Simms, V. M., Dzapasi, L., Chapoterera, G., Goba, N., Gumunyu, T., Weiss, H. A., Verhey, R., Abas, M., Araya, R., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5117-2 · Cited by 64
The Brain–Gut–Microbiome Axis in Psychiatry
Jang, S.-H., Woo, Y. S., Lee, S.-Y., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197122 · Cited by 65
“The global burden of this disease is high [69].”
BackgroundWang, Z., Yang, H., Guo, Z., Liu, B., & Geng, S. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2305-2 · Cited by 60
Is it depression or is it bipolar depression?
Rolin, D., Whelan, J., & Montano, C. B. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000499 · Cited by 54
Verplaetse, T. L., Moore, K. E., Pittman, B. P., Roberts, W., Oberleitner, L., Smith, P. H., Cosgrove, K., & McKee, S. A. (2018) · Chronic Stress · doi:10.1177/2470547017752637 · Cited by 60
García‐Rizo, C., & Bitanihirwe, B. K. Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109910 · Cited by 60
MRI predictors of pharmacotherapy response in major depressive disorder
Gerlach, A. R., Karim, H. T., Peciña, M., Ajilore, O., Taylor, W. D., Butters, M. A., & Andreescu, C. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2022.103157 · Cited by 57
“Major Depressive Disorder (MDD) is among the most ubiquitous psychiatric disorders affecting nearly 300 million people worldwide (Whiteford et al., 2010), with the highest disability-adjusted life years of any mental illness (Murray et al., 2012).”
BackgroundPsychological factors as risk factors for poor hip function after total hip arthroplasty
Benditz, A., Jansen, P., Schaible, J., Roll, C., Grifka, J. K., & Götz, J. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s127868 · Cited by 57
“14 The prevalence of these factors is likely to increase in the coming years.”
Whitehurst, T. S., Osugo, M., Townsend, L., Shatalina, E., Vava, R., Onwordi, E. C., & Howes, O. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.001 · Cited by 52
Macinko, J., Mullachery, P., Silver, D., Jimenez, G., & Libanio Morais Neto, O. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134153 · Cited by 44
Global Priorities for Addressing the Burden of Mental, Neurological, and Substance Use Disorders
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · Disease Control Priorities, Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders · doi:10.1596/978-1-4648-0426-7_ch1 · Cited by 53
Self-citationJNK Regulation of Depression and Anxiety
Hollós, P., Marchisella, F., & Coffey, E. T. (2017) · Brain Plasticity · doi:10.3233/bpl-170062 · Cited by 59
“Anxiety and depression are among the largest causes of disability worldwide [1].”
Gailits, N., Mathias, K. R., Nouvet, É., Pillai, P., & Schwartz, L. J. (2019) · BMC Public Health · doi:10.1186/s12889-019-7019-3 · Cited by 61
Mental health care and delivery system at Temeke hospital in Dar es Salaam, Tanzania
Ambikile, J. S., & Iseselo, M. K. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1271-9 · Cited by 64
Adewuya, A. O., Momodu, O., Olibamoyo, O., Adegbaju, A., Adesoji, O., & Adegbokun, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.025 · Cited by 56
Bőthe, B., Vaillancourt‐Morel, M., Bergeron, S., Hermann, Z., Ivaskevics, K., Kraus, S. W., & Grubbs, J. B. (2024) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000913 · Cited by 58
Haroz, E. E., Bolton, P., Gross, A., Chan, K. S., Michalopoulos, L., & Bass, J. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1218-3 · Cited by 49
Formánek, T., Kågström, A., Čermáková, P., Csémy, L., Mladá, K., & Winkler, P. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.05.001 · Cited by 55
A self-learned decomposition and classification model for schizophrenia diagnosis
Khare, S. K., & Bajaj, V. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106450 · Cited by 57
Metadata
- Authors
- Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T.
- Affiliations
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Auckland University of Technology (NZ)
- University of Washington (US)
- Corresponding author
- Whiteford, Harvey A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-06
- Volume
- 10
- Issue
- 2
- Pages
- e0116820
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4320057
- OpenAlex
- W2006103193
- Semantic Scholar
- 29fdb08fe359a077ba5ecfea8813becf7defce8c
- Cited by
- 1,175
- References
- 47
- Citations by year
- 2026: 34 · 2025: 63 · 2024: 83 · 2023: 111 · 2022: 121 · 2021: 142 · 2020: 145 · 2019: 143 · 2018: 123 · 2017: 113 · 2016: 66 · 2015: 29
- FWCI
- 180.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation
- Australian Government
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council (1041742)
- National Drug and Alcohol Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- mental illness, neurological disorders, substance use disorders, global burden of disease, disability-adjusted life years, years lived with disability, prevalence trends, sex differences, age differences, regional variation, schizophrenia, Parkinson's disease, epilepsy
- MeSH terms
- Age Factors, Bayes Theorem, Mental Disorders, Female, Geography, Humans, Male, Nervous System Diseases, Regression Analysis, Time Factors, Global Health, Prevalence, Cost of Illness, Quality-Adjusted Life Years, Substance-Related Disorders, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.